Refine Search

New Search

Result: 1

(searched for: (10.5155/eurjchem.6.4.461-467.1321))
Save to Scifeed
Page of 1
Articles per Page
by
Show export options
  Select all
Monther F. Mahdi , Ayad Mohammed Rasheed Raauf, Noor Muneer Mohammed
European Journal of Chemistry, Volume 6; doi:10.5155/eurjchem.6.4.461-467.1321

Abstract:
A series of six pyrazoline ring derivatives as a pharmacophore were incorporated to the naproxen; to increase its size were synthesized and preliminarly evaluated as anti-inflammatory agents with expected selectivity toward COX-2 enzyme. In vivo acute anti-inflammatory effects of the final compounds (5a-f) were evaluated in rats using egg-white induced edema model of inflammation. The tested compounds and the reference drug (naproxen) produced significant reduction of paw edema with respect to the effect of control group (propylene glycol 50%, v:v). However, compound 5d and 5e show comparable effect to naproxen at all experimental time while compounds 5a, 5b and 5c produced significantly lower inhibitory effect than naproxen at time 120-240 minutes. Furthermore, compound 5f exert significantly higher paw edema reduction than naproxen at 60-240 min. Also the antibacterial activities of the final compounds were evaluated by Well Diffusion Method. All tested compounds exert significant antibacterial activity against tested Gram positive and Gram negative bacteria in comparison to dimethyl sulfoxide as control group. In comparison the antibacterial results among the tested compound 5e may regard the best one and compound 5c the lower one.
Page of 1
Articles per Page
by
Show export options
  Select all
Back to Top Top